Delivery oder for spironolactone tablets.
Ended Awarded
- Contract number
- 36E79719N0049
- Awardee
-
Mylan Pharmaceuticals Inc. UEI NDN1MYB8DKK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Obligated
- $78,584
Award facts
- Contract value 100% obligated
- $78,584.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Everettville, WV 26505, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price delivery order awarded to Mylan Pharmaceuticals Inc. by the Department of Veterans Affairs (VA) National Acquisition Center. The contract, valued at $78,584.40, is for the delivery of spironolactone tablets to support the VA Pharmaceutical Prime Vendor program. Spironolactone is a medication used to treat conditions such as heart failure and high blood pressure. This delivery order is issued under Mylan's existing Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs with the VA. Mylan is a for-profit manufacturer of pharmaceutical goods and has a history of providing critical medications to federal agencies, including the VA, Department of Defense, and Bureau of Prisons. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36E79719N0049?
36E79719N0049 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 10, 2019.
How much is contract 36E79719N0049 worth?
The government has obligated $78,584 on 36E79719N0049.
Is contract 36E79719N0049 an order under another contract?
Yes. 36E79719N0049 is a BPA call under V797D30107-VA797P15A0009, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79719N0049 competed?
The extent of competition for 36E79719N0049 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award